Next, accordingly to the strong inhibition of tumor growth, a significant reduction in phosphorylated ERK 1/2 and Akt – key signaling molecules downstream of CD44 [54] – was observed in the tumors of mice treated with sTN58 (Fig. 7E and F). Here, AKT1 is linked to neoplasm.